Market Cap ₹71 Cr.
Stock P/E 0.0
P/B 1
Current Price ₹37.8
Book Value ₹ 37.7
Face Value 10
52W High ₹100
Dividend Yield 0%
52W Low ₹ 31.9
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|
Net Sales | 278 | 223 | 269 | 296 | |
Other Income | 1 | 1 | 1 | 1 | |
Total Income | 278 | 224 | 270 | 297 | |
Total Expenditure | 268 | 215 | 258 | 278 | |
Operating Profit | 10 | 8 | 12 | 19 | |
Interest | 6 | 6 | 8 | 9 | |
Depreciation | 2 | 1 | 1 | 1 | |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | |
Profit Before Tax | 2 | 1 | 2 | 10 | |
Provision for Tax | 1 | 1 | 1 | 3 | |
Profit After Tax | 2 | 1 | 2 | 7 | |
Adjustments | 0 | 0 | 0 | 0 | |
Profit After Adjustments | 2 | 1 | 2 | 7 | |
Adjusted Earnings Per Share | 12.9 | 5.6 | 13.3 | 4.9 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 10% | 2% | 0% | 0% |
Operating Profit CAGR | 58% | 24% | 0% | 0% |
PAT CAGR | 250% | 52% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | NA% | NA% | NA% |
ROE Average | 40% | 20% | 18% | 18% |
ROCE Average | 26% | 20% | 20% | 20% |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Shareholder's Funds | 11 | 12 | 13 | 20 |
Minority's Interest | 0 | 0 | 0 | 0 |
Borrowings | 22 | 24 | 20 | 18 |
Other Non-Current Liabilities | -1 | -1 | -1 | -1 |
Total Current Liabilities | 23 | 30 | 50 | 56 |
Total Liabilities | 55 | 64 | 83 | 94 |
Fixed Assets | 19 | 19 | 19 | 18 |
Other Non-Current Assets | 5 | 13 | 13 | 15 |
Total Current Assets | 31 | 32 | 51 | 61 |
Total Assets | 55 | 64 | 83 | 94 |
#(Fig in Cr.) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Opening Cash & Cash Equivalents | 2 | 3 | 3 | 8 |
Cash Flow from Operating Activities | 1 | 2 | -0 | 7 |
Cash Flow from Investing Activities | -1 | -1 | -0 | -0 |
Cash Flow from Financing Activities | 1 | -0 | 5 | -4 |
Net Cash Inflow / Outflow | 1 | 1 | 5 | 2 |
Closing Cash & Cash Equivalent | 3 | 3 | 8 | 10 |
# | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|
Earnings Per Share (Rs) | 12.89 | 5.57 | 13.27 | 4.93 |
CEPS(Rs) | 25.21 | 15.27 | 22.3 | 5.62 |
DPS(Rs) | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 88.81 | 94.38 | 107.65 | 14.71 |
Core EBITDA Margin(%) | 3.41 | 3.5 | 4.01 | 6.09 |
EBIT Margin(%) | 3.06 | 3.2 | 3.92 | 6.22 |
Pre Tax Margin(%) | 0.86 | 0.57 | 0.9 | 3.34 |
PAT Margin (%) | 0.58 | 0.31 | 0.61 | 2.27 |
Cash Profit Margin (%) | 1.13 | 0.85 | 1.03 | 2.59 |
ROA(%) | 2.92 | 1.16 | 2.24 | 7.62 |
ROE(%) | 14.51 | 6.08 | 13.13 | 40.22 |
ROCE(%) | 21.05 | 15.75 | 18.29 | 26.08 |
Receivable days | 0.89 | 0.76 | 0.48 | 0.36 |
Inventory Days | 25.89 | 37.16 | 43.23 | 51.82 |
Payable days | 19.15 | 21.53 | 18.87 | 18.44 |
PER(x) | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.1 | 0.16 | 0.17 | 0.2 |
EV/Core EBITDA(x) | 2.76 | 4.35 | 3.84 | 3.06 |
Net Sales Growth(%) | 0 | -19.65 | 20.69 | 9.85 |
EBIT Growth(%) | 0 | -15.89 | 47.86 | 74.38 |
PAT Growth(%) | 0 | -56.8 | 138.21 | 308.5 |
EPS Growth(%) | 0 | -56.8 | 138.21 | -62.86 |
Debt/Equity(x) | 2.66 | 3.29 | 3.87 | 2.78 |
Current Ratio(x) | 1.35 | 1.08 | 1.01 | 1.08 |
Quick Ratio(x) | 0.49 | 0.21 | 0.26 | 0.26 |
Interest Cover(x) | 1.39 | 1.22 | 1.3 | 2.16 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 |
# | Jan 1970 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|
Promoter | 73.06 | 73.06 | 73.06 | 73.06 |
FII | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 |
Public | 26.94 | 26.94 | 26.94 | 26.94 |
Others | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 |
# | Jan 1970 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|
Promoter | 1.37 | 1.37 | 1.37 | 1.37 |
FII | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 |
Public | 0.5 | 0.5 | 0.5 | 0.5 |
Others | 0 | 0 | 0 | 0 |
Total | 1.87 | 1.87 | 1.87 | 1.87 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About